Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,309,379
-
Share change
-
-652,931
-
Total reported value
-
$2,425,234
-
Price per share
-
$1.05
-
Number of holders
-
24
-
Value change
-
-$649,432
-
Number of buys
-
6
-
Number of sells
-
7
Institutional Holders of Sensei Biotherapeutics, Inc. - COM (SNSE) as of Q1 2024
As of 31 Mar 2024,
Sensei Biotherapeutics, Inc. - COM (SNSE) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,309,379 shares.
The largest 10 holders included
Newtyn Management, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, NORTHERN TRUST CORP, and STATE STREET CORP.
This page lists
24
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.